Advanced Macular
Degeneration Treatment in Las Vegas
Meticulous, Data-Driven Retinal Diagnostics and Care Silos in Summerlin.
Macular degeneration treatment at Precise Sight focuses on preserving central visual acuity by slowing the progression of retinal cellular damage. Managed by board-certified ophthalmologist Dr. Eissa Hanna and clinical optometrist Dr. Justin Hart in Summerlin, Las Vegas, NV, our boutique practice provides advanced optical coherence tomography (OCT) tracking, medical risk mitigation, and coordinated specialist networks to manage dry and wet age-related macular degeneration (AMD).
The Underlying Mechanisms of Age-Related Macular Degeneration (AMD)
Age-Related Macular Degeneration (AMD) is a progressive ocular disease that affects the macula—the small, highly sensitive central portion of the retina responsible for providing the sharp, straight-ahead vision needed for reading, recognizing faces, and driving safely. AMD leaves peripheral vision completely intact but can cause a dark, blurry, or distorted blind spot directly in the center of your sight.
The disease progresses through two primary physiological forms, requiring distinct clinical tracking paths:
Dry AMD (Non-Exudative):
Accounting for approximately 80% to 90% of all diagnoses, Dry AMD develops gradually as aging retinal metabolic clearance slows. This leads to the accumulation of microscopic, yellow extracellular debris deposits called drusen beneath the retina. Over time, expanding drusen layers restrict nutritional blood delivery, causing progressive thinning and wasting (atrophy) of vital light-sensitive macular cells.
Wet AMD (Exudative):
While less common, Wet AMD is an aggressive, fast-moving phase that accounts for the majority of severe, sudden vision loss. It occurs when progressive cellular stress triggers the release of abnormal chemical growth signals, causing fragile, erratic new blood vessels to sprout beneath the macula. These abnormal vessels easily leak blood, lipids, and fluid into the retinal layers, immediately lifting the macula out of position and causing straight lines to appear wavy or distorted (metamorphopsia).
University-Grade Imaging Suite for Meticulous Retinal Tracking
Because cellular adjustments within the deep layers of the retina often occur long before you notice physical blind spots, Precise Sight utilizes advanced, non-invasive digital diagnostic technology. This objective data allows us to intercept progression at the structural level:
High-Resolution Macular OCT (Spectral-Domain)
This diagnostic system takes cross-sectional laser scans of your retinal layers with micron-level accuracy. It functions as an in-vivo optical biopsy, allowing Dr. Hanna to visually inspect the sub-retinal layers for early drusen accumulation, localized geographic atrophy, or microscopic fluid pockets indicating a shift toward Wet AMD.
Digital Fundus Topography & Autofluorescence
Advanced imaging that evaluates the metabolic health of the Retinal Pigment Epithelium (RPE), highlighting active cellular stress patterns and geographic atrophy boundaries without invasive dye tracking.
Automated Macular Perimetry & Amsler Grid Refinement
Precision objective testing that maps the absolute sensitivity of your central visual field, identifying localized visual distortions down to fractions of a degree.
Targeted Medical Care Paths and Progression Management
Treatment frameworks for macular degeneration are highly customized based on your exact diagnostic staging, focusing on slowing structural cellular decline and stabilizing vascular walls:
Following strict evidence-based medicine benchmarks established by the National Eye Institute’s AREDS2 clinical trials, we design targeted high-dose antioxidant and zinc supplementation regimens. This protocol has been clinically proven to significantly reduce the risk of intermediate dry AMD transitioning into advanced stages.
Our medical team provides collaborative cardiovascular and lifestyle oversight, managing modifiable risks such as ultraviolet (UV) light exposure, smoking-induced oxidative stress, and blood pressure fluctuations that directly accelerate macular cell death.
For patients displaying active fluid leakage, our clinical pipeline coordinates seamlessly with premier regional retinal surgical specialists. This protocol delivers targeted micro-injections of Anti-Vascular Endothelial Growth Factor (anti-VEGF) medications directly into the vitreous space, safely drying up abnormal vessel leakages and preserving long-term central clarity.
Quantifiable Safety Standards and Population Vulnerability
Evaluating objective data points helps our clinical team structure highly proactive vision preservation plans for families throughout Summerlin and the wider Las Vegas Valley.
25%
Risk Reduction:
Successfully achieved in dry AMD progression profiles by adhering to precise, daily AREDS2 nutritional interventions.
90% Vision Stabilization Rate:
Realized across modern anti-VEGF therapeutic paths for wet AMD cases, permanently altering historical blindness timelines.
Under 5 Micron Optical Resolution:
Achieved across our high-resolution SD-OCT systems to capture early fluid shifts beneath the retinal layers.
A Consultative Approach to Retinal Health Retention
"Macular degeneration cannot be treated passively. We do not wait for a patient to describe a permanent blind spot before we take action. By utilizing high-resolution retinal OCT tracking, we can monitor the health of deep retinal cells down to the micron. This allows us to apply early lifestyle and targeted medical protocols that safely defend central vision, helping our patients maintain their independent, active lives in Summerlin."
